{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:45:38Z","timestamp":1769085938831,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijid.2025.108206","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T09:49:18Z","timestamp":1762768158000},"page":"108206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Brivudine for treatment of varicella-zoster virus encephalitis"],"prefix":"10.1016","volume":"162","author":[{"given":"Zhaozhao","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijid.2025.108206_bib0001","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/v15081663","article-title":"The spectrum of neurological manifestations of varicella\u2013zoster virus reactivation","volume":"15","author":"Kennedy","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijid.2025.108206_bib0002","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.ijid.2025.108206_bib0003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2015.06.004","article-title":"Varicella-zoster virus infections of the central nervous system \u2013 prognosis, diagnostics and treatment","volume":"71","author":"Grahn","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.108206_bib0004","doi-asserted-by":"crossref","first-page":"1509630","DOI":"10.3389\/fcimb.2024.1509630","article-title":"Metagenomic next-generation sequencing of cerebrospinal fluid: a diagnostic approach for varicella zoster virus-related encephalitis","volume":"14","author":"Tang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2025.108206_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3344\/kjp.22391","article-title":"Current scenario and future applicability of antivirals against herpes zoster","volume":"36","author":"Kim","year":"2023","journal-title":"Korean J Pain"},{"issue":"16","key":"10.1016\/j.ijid.2025.108206_bib0006","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1021\/acs.jmedchem.9b00175","article-title":"Fifty years in search of selective antiviral drugs","volume":"62","author":"De Clercq","year":"2019","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.ijid.2025.108206_bib0007","doi-asserted-by":"crossref","first-page":"e2554","DOI":"10.1002\/rmv.2554","article-title":"Varicella-zoster virus-related neurological complications: from infection to immunomodulatory therapies","volume":"34","author":"Hakami","year":"2024","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.ijid.2025.108206_bib0008","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/j.1432-2277.2009.01045.x","article-title":"Epstein-Barr virus encephalitis after kidney transplantation and successful treatment with brivudine","volume":"23","author":"Lahmer","year":"2010","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.ijid.2025.108206_bib0009","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1358\/dot.2003.39.5.740221","article-title":"Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing","volume":"39","author":"Rabasseda","year":"2003","journal-title":"Drugs Today"},{"issue":"1","key":"10.1016\/j.ijid.2025.108206_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0166-3542(83)90010-4","article-title":"Efficacy of (E)-5-(2-bromovinyl)-2\u2032-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice","volume":"3","author":"Park","year":"1983","journal-title":"Antiviral Res"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122500428X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122500428X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:31:55Z","timestamp":1766406715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122500428X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":10,"alternative-id":["S120197122500428X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108206","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brivudine for treatment of varicella-zoster virus encephalitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108206"}}